Pressreleases

ERT Supports Improved Healthcare Delivery in Low-Resource Areas

ECG Device Donations Enable Effective Cardiac Health Monitoring throughout Haiti.

ERT Announces Acquisition of eClinical Insights

Combined Offering Enables Real Time Decision Making in Global Clinical Trials.

ERT’s Scientific and Regulatory Consultants Support Phase III Oncology Trial

Provectus Biopharmaceuticals Collaborates with ERT’s COA Experts to Understand Patient Perspective during Melanoma Drug Development.

ERT Maintains Top Level of Drug Approval Support

ERT’s Solutions Utilized in over Half of FDA Approvals.

Sartorius Closes Sale of Industrial Technologies Division

Sartorius, a leading international laboratory and pharmaceutical equipment provider, completed the sale of its Industrial Technologies Division to the Japanese Minebea Co., Ltd. and their partner, the Development Bank of Japan Inc., which had been agreed on December 19, 2014. The cash proceeds resulting from this transaction total approximately €90 million.

Sartorius has closed the sale of its Industrial Technologies Division

Sartorius have signed an agreement with the Japanese Minebea Group about the sale of our Industrial Technologies Division (Intec). The sales transaction is expected to be completed already in the first quarter of 2015. Based on our intensive negotiations with the future owner, we are convinced that Minebea will offer an excellent new roof for our Intec activities to enable the further dynamic development and internationalisation of this business. Given the portfolios and the regional presence of both companies, there is a strong complementary fit and thus significant synergy potential for the further profitable growth of this activity.

3R Pharma Present at Stability Conference

3R Pharma managing director Manuel Zahn will lead workshops, conferences and seminars this March.

Woodley Equipment Company Inc. Exhibiting at Outsourcing in Clinical Trials West Coast

Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast taking place at the Hyatt Regency San Francisco Airport Hotel on 3 – 4 February 2015.

Malvern’s new OMNISEC GPC/SEC Platform Brings Ground-Breaking Performance to the Analysis of Polymers, Proteins and other Macromolecules

A completely new gel permeation/size exclusion chromatography (GPC/SEC) platform from Malvern Instruments breaks new ground in delivering the high performance, ease of use and productivity demanded in today’s analytical laboratories. Malvern’s innovative OMNISEC platform integrates highly efficient sample separation via the OMNISEC RESOLVE module and high sensitivity analysis using OMNISEC REVEAL, a fully integrated multi-detector array. The system has applications wherever there is a need for detailed analysis and understanding of natural or synthetic polymers, proteins and macromolecules.